Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FD1BV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,561
Award facts
- Contract value 100% obligated
- $8,561.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,561.15 by the Defense Logistics Agency on September 18, 2025. The contract covers the delivery of XOLAIR 300 MG/2 ML auto-injector doses, a biologic medication used to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria. Performance is scheduled for completion by October 9, 2025, with delivery to Park Ridge, Illinois. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, valued at $499,999,999 and effective through November 2026. The IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. Through this vehicle, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering specialized medications and medical supplies to military health systems.
Quick answers
Who was awarded contract SPE2DB25FD1BV?
SPE2DB25FD1BV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FD1BV worth?
The government has obligated $8,561 on SPE2DB25FD1BV.
Is contract SPE2DB25FD1BV an order under another contract?
Yes. SPE2DB25FD1BV is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FD1BV competed?
The extent of competition for SPE2DB25FD1BV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award